TIBER CREEK GROUP for MERCK & CO., INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug pricing, reimbursement for prescription drugs, and the pharmaceutical supply chain; H.R. 6833/S. 3700 - Affordable Insulin Now Act; S. 2199 - Insulin Price Reduction Act; S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022; H.R. 7667 - Food and Drug Amendments of 2022; The Continuing resolution and Ukraine Supplemental Appropriations Act 2023 (PL 117-180), Division F - FDA User Fee Reauthorization Act of 2022; H.R. 7559 - the Prescription Information Modernization Act; Package Inserts/eLabeling Issues (H.R. 7559, Prescription Information Modernization Act of 2022).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
| ANDREW MCKECHNIE | — |
Medicare/Medicaid MMM
H.R. 5376 - Build Back Better, Subtitle J; Inflation Reduction Act of 2022 (PL 117-169), Subtitle B - Prescription Drug Pricing Reform; issues relating to Medicare Part D and Part B Pricing Reform; Issues related to capping out-of-pocket costs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
| ANDREW MCKECHNIE | — |
Trade (domestic/foreign) TRD
Issues relating to Intellectual Property protections for Covid-19 treatments and vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.